These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 7660791)
21. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens. Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172 [TBL] [Abstract][Full Text] [Related]
22. Assessment of converting from intravenous to oral administration of cyclosporin A in pediatric allogeneic hematopoietic stem cell transplant recipients. Choi JS; Lee SH; Chung SJ; Yoo KH; Sung KW; Koo HH Bone Marrow Transplant; 2006 Jul; 38(1):29-35. PubMed ID: 16715103 [TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%. Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients. Jankovic SM; Milovanovic JR Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330 [TBL] [Abstract][Full Text] [Related]
25. Specific monoclonal radioimmunoassay and fluorescence polarization immunoassay for trough concentration and area-under-the-curve monitoring of cyclosporine in renal transplantation. Lindholm A; Napoli K; Rutzky L; Kahan BD Ther Drug Monit; 1992 Aug; 14(4):292-300. PubMed ID: 1519303 [TBL] [Abstract][Full Text] [Related]
26. [Oral cyclosporine pharmacokinetics in renal transplantation patients]. Zhuo HT; Chen G Yao Xue Xue Bao; 1990; 25(1):1-5. PubMed ID: 2363351 [TBL] [Abstract][Full Text] [Related]
27. Comparison of nonspecific radioimmunoassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for cyclosporine monitoring in renal transplantation. Lee SF; Yang WC; Shann TY; Lui WY; Wang RB Ther Drug Monit; 1991 Mar; 13(2):152-6. PubMed ID: 2053123 [TBL] [Abstract][Full Text] [Related]
28. Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart, and liver transplantation. Winkler M; Schumann G; Petersen D; Oellerich M; Wonigeit K Clin Chem; 1992 Jan; 38(1):123-6. PubMed ID: 1733584 [TBL] [Abstract][Full Text] [Related]
29. Factors affecting oral cyclosporin disposition after heart transplantation: bootstrap validation of a population pharmacokinetic model. Parke J; Charles BG Eur J Clin Pharmacol; 2000 Sep; 56(6-7):481-7. PubMed ID: 11049011 [TBL] [Abstract][Full Text] [Related]
30. Comparison of a monoclonal antibody fluorescent polarization immunoassay with monoclonal antibody radioimmunoassay for cyclosporin determination in whole blood. Alvarez JS; Sacristan JA; Alsar MJ Ther Drug Monit; 1992 Feb; 14(1):78-80. PubMed ID: 1546394 [TBL] [Abstract][Full Text] [Related]
31. Slow accumulation of cyclosporin metabolites as measured by specific and nonspecific cyclosporin RIA. Keller F; Kunzendorf U; Walz G; Schwarz A; Offermann G Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):167-75. PubMed ID: 2338370 [TBL] [Abstract][Full Text] [Related]
32. Analysis of whole-blood cyclosporin G by liquid chromatography in renal transplant recipients. McBride JH; Kim SS J Clin Lab Anal; 1995; 9(4):238-42. PubMed ID: 7562241 [TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics of valnemulin in swine. Zhao DH; Zhang Z; Zhang CY; Liu ZC; Deng H; Yu JJ; Guo JP; Liu YH J Vet Pharmacol Ther; 2014 Feb; 37(1):59-65. PubMed ID: 23617793 [TBL] [Abstract][Full Text] [Related]
34. Population Pharmacokinetic Approach to the Use of Low Dose Cyclosporine in Patients with Connective Tissue Diseases. Tsuji Y; Iwanaga N; Mizoguchi A; Sonemoto E; Hiraki Y; Ota Y; Kasai H; Yukawa E; Ueki Y; To H Biol Pharm Bull; 2015; 38(9):1265-71. PubMed ID: 26328482 [TBL] [Abstract][Full Text] [Related]
35. Utility of pretransplantation cyclosporine pharmacokinetic studies. Cooney GF; Heifets M; Bell A; Shaw LM; LiBetti G Ther Drug Monit; 1994 Apr; 16(2):151-4. PubMed ID: 8009562 [TBL] [Abstract][Full Text] [Related]
36. [Informative value of methods for determining cyclosporin A and its metabolites during its monitoring in blood of patients with a transplanted kidney]. Siniukhin VH; Nikolaeva NP; Iarmolinskiĭ IS; Darenkov AF Vopr Med Khim; 1991; 37(3):83-5. PubMed ID: 1949700 [No Abstract] [Full Text] [Related]
37. Comparison of high-performance liquid chromatography and monoclonal fluorescence polarization immunoassay for the determination of whole-blood cyclosporin A in liver and heart transplant patients. Taylor PJ; Salm P; Norris RL; Ravenscroft PJ; Pond SM Ther Drug Monit; 1994 Oct; 16(5):526-30. PubMed ID: 7846754 [TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients. Zhou H; Gao Y; Cheng XL; Li ZD Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):271-8. PubMed ID: 22446981 [TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of flucytosine: comparison and validation of three models using STS, NPEM, and NONMEM. Vermes A; Math t RA; van der Sijs IH; Dankert J; Guchelaar HJ Ther Drug Monit; 2000 Dec; 22(6):676-87. PubMed ID: 11128235 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and absolute bioavailability of cyclosporin following intravenous and abomasal administration to sheep. Charles BG; Filippich LJ; Pass MA J Pharm Pharmacol; 1993 Sep; 45(9):821-4. PubMed ID: 7903372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]